OACC
Oaktree Acquisition Corp. III Life Sciences
10.80$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +531.5% | +46.5% | -39.3% | -16.4% | +13.3% | +78.7% | -42.6% | – | |
| – | +531.5% | +46.5% | -39.3% | -16.4% | +13.3% | +78.7% | -42.6% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +20.2% | +13.0% | +4.9% | -9.0% | -22.1% | +15.1% | – | |
| – | – | +20.2% | +13.0% | +4.9% | -9.0% | -22.1% | +15.1% | – | |
| – | – | – | -116.3% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.